| Sažetak | Cilj istraživanja: Svrha ovog istraživanja bila je procijeniti kvalitetu života i kvalitetu spavanja u bolesnika s dijagnosticiranim srčanim zatajivanjem.
Materijali i metode: U ovo presječno anketno istraživanje je uključeno ukupno 32 ispitanika s dijagnosticiranim zatajivanjem srca (17 muškaraca i 15 žena). Svi uključeni ispitanici su bili liječeni na Klinici za bolesti srca i krvnih žila KBC-a Split tijekom razdoblja od 1. siječnja 2018. do 1. svibnja 2018. godine. Ispitanici su ispunjavali upitnik koji je procjenjivao kvalitetu života u bolesnika sa zatajivanjem srca (engl. Minnesota Living with Heart Failure Questionnaire - MLHFQ), te upitnik koji je procjenjivao kvalitetu spavanja u posljednjih mjesec dana (engl. Pittsburgh Sleep Quality Indeks - PSQI).
Rezultati: Najveći broj ispitanika je klasificiran kao NYHA stupanj 3 (N=21; 65,6%), dok ih je nešto manje klasificirano kao NYHA stupanj 4 (N=9; 28,1%) i NYHA stupanj 2 (N=2; 6,3%). Najveći udio ispitanika ima pridruženu arterijsku hipertenziju (N=30), dok ih manji broj ima pridruženu atrijsku fibrilaciju (N=21), šećernu bolest (N=10) i povijest akutnog koronarnog sindroma (N=13). U pacijenata s ishemijskim tipom je prisutan značajno viši NYHA stadij srčanog zatajenja (3,44 ± 0,51 vs. 3,00 ± 0,51; P=0,023), te značajno više muškaraca je ima naspram žena (N=12, 70,6% vs. N=4, 26,7%; P=0,032). Prosječni rezultat na PSQI upitniku je bio 13,62 ± 4,81, te je većina pacijenata klasificirana u skupinu onih koji imaju lošu kvalitetu spavanja (N=31; 96,88%). Prosječan zbroj bodova postignut na MLFHQ upitniku je iznosio 63,66 ± 22,2, te se pokazalo da ispitanici s većim NYHA stupnjem zatajenja imaju značajno veći MLHFQ zbroj (20,05 ± 13,43 vs. 64,01 ± 22,24 vs. 79,05 ± 17,01; P=0,001). Nema statistički značajne razlike u MLFHQ i PSQI prosječnom zbroju bodova u odnosu na spol i vrstu kardiomiopatije. Statistički značajna pozitivna korelacija je pronađena između MLHFQ zbroja bodova i globalnog PSQI zbroja bodova (r=0,387; P=0,029).
Zaključci: Većina pacijenata sa srčanim zatajivanjem ima lošu kvalitetu spavanja, dok veći stupanj zatajenja prema NYHA klasifikaciji uzrokuje značajno lošiju kvalitetu života. |
| Sažetak (engleski) | Objectives: The purpose of this study was to evaluate the quality of life and sleep in patients with diagnosed cardiac failure.
Materials and methods: In this cross-sectional survey, a total of 32 subjects with diagnosed heart failure (17 males and 15 females) were included. All involved subjects were treated at the Clinic for Heart and Blood Diseases, University Hospital of Split during the period from January to May 2018. The respondents completed a questionnaire that evaluated the quality of life (Minnesota Living with Heart Failure Questionnaire – MLHFQ), and a questionnaire that evaluated sleep quality in the past month (Pittsburgh Sleep Quality Indeks - PSQI).
Results: The highest number of subjects was classified as NYHA level 3 (N = 21, 65.6%), while smaller number was classified as NYHA grade 4 (N = 9, 28.1%) and NYHA grade 2 (N = 2; 6,3%). The largest proportion of subjects had associated arterial hypertension (N=30), while other patients had associated atrial fibrillation (N=21), diabetes mellitus (N=10) and history of acute coronary syndrome (N=13). Significantly higher NYHA heart failure degree was present in patients with ischemic disease (3.44 ± 0.51 vs. 3.00 ± 0.51, P=0.023), and significantly more males had ischemic type when compared to women (N=12, 70.6% vs. N=4, 26.7%, P=0.032). The average score for the PSQI test was 13.62 ± 4.81, and most patients were classified in the group with low sleep quality (N=31, 96.88%). The average score of the MLFHQ questionnaire was 63.66 ± 22.2 and it was shown that subjects with a higher NYHA degree of failure had a significantly higher MLHFQ score (20.05 ± 13.43 versus 64.01 ± 22.24 vs. 79.0 ± 17.01; P=0.001). There are no statistically significant differences in MLFHQ and PSQI average scores in relation to gender and type of cardiomyopathy. A statistically significant positive correlation was found between the MLHFQ score and the global PSQI score (r = 0.387; P=0.029).
Conclusions: Most patients with heart failure have poor sleep quality, while a higher degree of failure according to the NYHA classification results in significantly lower quality of life. |
